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Abstract
Author Manuscript

The developmental course of daily functioning prior to first psychosis-onset remains poorly
understood. This study explored age-related periods of change in social and role functioning. The
longitudinal study included youth (aged 12–23, mean follow-up years = 1.19) at clinical high risk
(CHR) for psychosis (converters [CHR-C], n = 83; nonconverters [CHR-NC], n = 275) and a
healthy control group (n =164). Mixed-model analyses were performed to determine age-related
differences in social and role functioning. We limited our analyses to functioning before psychosis
conversion; thus, data of CHR-C participants gathered after psychosis onset were excluded. In
controls, social and role functioning improved over time. From at least age 12, functioning in CHR
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was poorer than in controls, and this lag persisted over time. Between ages 15 and 18, social
functioning in CHR-C stagnated and diverged from that of CHR-NC, who continued to improve
( p = .001). Subsequently, CHR-C lagged behind in improvement between ages 21 and 23, further
distinguishing them from CHR-NC ( p < .001). A similar period of stagnation was apparent for
role functioning, but to a lesser extent ( p = .007). The results remained consistent when we
accounted for the time to conversion. Our findings suggest that CHR-C start lagging behind CHRNC in social and role functioning in adolescence, followed by a period of further stagnation in
adulthood.

Author Manuscript

Disability in people with schizophrenia is evident in multiple areas of functioning, such as
the quality of social contact and the fulfillment of roles at school or work (Green, Llerena, &
Kern, 2015; Harvey et al., 2012). Although the importance of impaired social and role
functioning as fundamental components of schizophrenia have been increasingly
acknowledged (Burns & Patrick, 2007), little is known about their exact developmental
course.

Author Manuscript

Studies of intellectual ability in schizophrenia indicate a slower increase in functioning in
individuals who later develop the illness relative to the more rapid growth of healthy
individuals (Reichenberg et al., 2010), indicating that cognitive abilities of future
schizophrenia patients do increase over time, but with a pace slower than that of those who
will never develop the illness. This finding is in congruence with the neurodevelopmental
model, in which it is assumed that premorbid deficits in schizophrenia result from early
neurodevelopmental disturbances, making it difficult to keep up with the “normal”
functional growth that occurs later in life (Murray, O’Callaghan, Castle, & Lewis, 1992;
Schmidt-Kastner, van Os, Esquivel, Steinbusch, & Rutten, 2012; Weinberger, 1987). The
decade between early adolescence and young adulthood is specifically critical in this regard,
as it has been suggested to represent a period during which growing societal/environmental
challenges may negatively impact the final stages of brain maturation (Selemon & Zecevic,
2015; Weinberger, 1987).

Author Manuscript

In individuals who later develop schizophrenia, increasing deviations relative to the healthy
population, prior to illness onset, have also been observed at the level of social and
academic/vocational functioning (referred to as role functioning; Cole, Apud, Weinberger, &
Dickinson, 2012; Horton, Tarbox, Olino, & Haas, 2015; Shapiro et al., 2009). Extensive
work in this field stems from the 1950s, when Dr. Philips created the empirically derived
Premorbid Adjustment Scale to retrospectively assess premorbid social and role functioning
levels in patients diagnosed with schizophrenia (Phillips, 1953). Studies using the scale have
since pointed to considerable heterogeneity, but overall it tends to show growing levels of
premorbid social impairment in the phases closer to the illness (e.g., Allen, Frantom,
Strauss, & van Kammen, 2005; Hafner, Nowotny, Loffler, an der Heiden, & Maurer, 1995;
Monte, Goulding, & Compton, 2008; Strauss et al., 2012). Poorer premorbid functioning
scores were shown to be associated with worse symptom course and overall severity of
illness (Garmezy & Rodnick, 1959).
However, these previous studies generally used retrospective designs, introducing
methodological limitations, such as recall biases. Although one recent population-based
Dev Psychopathol. Author manuscript; available in PMC 2019 February 01.
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study showed a very similar pattern to the famous retrospective ABC studies (Hafner,
Loffler, Maurer, Hambrecht, & an der Heiden, 1999), with increasing impairment compared
to the general population in individuals tested closer to first hospitalization, this study
included only one data point per individual (Velthorst et al., 2015). Collectively, these
studies seem to point toward growing functional impairment over time, but longitudinal
prospective studies are needed to confirm cross-sectional observations.

Author Manuscript

In addition, relatively little is known about the functional trajectories in the years following
identification of risk of psychosis. Studying social and role functioning in this clinical high
risk (CHR) phase is important, as it may provide important clues about the early
developmental precursors of schizophrenia (Lin, Wood, & Yung, 2013). In most CHR
studies carried out thus far, functional impairment is typically viewed as a single construct
(e.g., as assessed with a single global assessment of functioning summary score; see Cotter
et al., 2014), but distinct developmental trajectories may characterize different functional
domains (Harvey et al., 2012). Previous studies from our group showed that, while
impairments in both role and social functioning are persistent in individuals at CHR for
psychosis (Addington, Cornblatt, et al., 2011), only deficits in the latter domain differentiate
between those who eventually do and do not convert to psychosis (Cannon et al., 2008;
Cornblatt et al., 2012), potentially suggestive of a differential developmental trajectory.
Clarification of this matter is particularly important from the perspective of treatment of
these different components of functional impairment.

Author Manuscript

In the present study, we explored if there are important periods during which impairments in
the two key components of community functioning (social functioning and role functioning)
start to become more pronounced in those who convert to psychosis. We compared the
developmental trajectories of the two domains among CHR individuals who later converted
to psychosis (CHR-C), CHR individuals who did not convert over a 2.5-year follow-up
period (CHR-NC), and a healthy comparison group. More specifically, we examined
whether the increased impairments over time in social and role functioning previously
observed in CHR-C could be attributed to (age-related periods of) stagnation, delayed
growth, or decline in functioning.

Methods
Subjects

Author Manuscript

We used data from 358 CHR and 164 healthy individuals (311 males, 211 females; baseline
age: M = 17.37, SD = 3.0) who were participants in the North American Prodrome
Longitudinal Study Phase 1 (NAPLS-1; Cannon et al., 2008) and/or the ongoing Center for
Assessment and Prevention of Prodromal States (CAPPS) study at the University of
California Los Angeles (UCLA) Semel Institute, and who had their baseline assessment in
the decade between early adolescence and early adulthood (ages 12–23). Table 1 provides a
detailed description of the baseline demographic and clinical characteristics broken down by
group status. Forty-two percent of our sample (n = 217) was recruited as part of the CAPPS
study. Of those, 41 (36 CHR, 5 controls) also participated in NAPLS-1. The other 176
CAPPS participants were recruited after the establishment of the NAPLS-1 cohort. CAPPS
and NAPLS-1 used identical inclusion criteria and study designs; all participants (CHR and
Dev Psychopathol. Author manuscript; available in PMC 2019 February 01.
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controls) were seen at 6-month intervals and prospectively followed for up to 2.5 years. At
the UCLA Semel Institute, the same interviewers performed all clinical interviews and
symptom ratings for both CAPPS and NAPLS-1.

Author Manuscript

CHR participants were help-seeking individuals who met criteria for one of three CHR
categories, as assessed with the Structured Interview for Prodromal Syndromes (SIPS;
McGlashan, Walsh, & Woods, 2010) by experienced MA/ PhD level clinicians: attenuated
psychotic symptoms; transient, recent-onset psychotic symptoms; or a substantial drop in
functioning in conjunction with schizotypal personality disorder or a first-degree relative
with psychosis. Participants were excluded for current or past diagnosis of an Axis I
psychotic disorder, including affective psychoses, as determined by the Structured Clinical
Interview for the DSM-IV (SCID; First, Spitzer, Gibbon, & Williams, 1997). Approximately
96% of the CHR participants met initial eligibility based on attenuated positive symptoms,
and 4% met initial eligibility based on brief intermittent psychotic symptoms. While only 2
(<1%) patients were ascertained as prodromal exclusively in the genetic risk and
deterioration category, 12% had a comorbid attenuated positive symptoms–genetic risk and
deterioration prodromal diagnosis.
The typically developing control sample, matched on age to the CHR sample, did not meet
CHR criteria or DSM-IV criteria for any major psychiatric disorder. Additional exclusion
criteria for all participants were as follows: neurological disorder, drug/alcohol abuse or
dependence within the past 6 months, insufficient English fluency, and/or IQ below 70 (see
(Addington et al., 2007, for more details regarding inclusion/ exclusion criteria and
diagnostic reliability procedures). The institutional review boards of the participating sites
approved study protocols and informed consent documents.

Author Manuscript

Measures

Author Manuscript

Symptomatology—The SIPS and the Scale for Assessment of Prodromal Syndromes
(McGlashan et al., 2010) were used to assess CHR criteria, severity of attenuated positive
symptoms and negative symptoms, and to define conversion to psychosis (Cannon et al.,
2008). Symptom domain scores were determined by the sum of symptom severity scores
within each domain (positive, negative, disorganized, and general symptoms). Full details
regarding SIPS criteria, reliability, and consensus procedures are described elsewhere
(Addington et al., 2007; Meyer et al., 2005). The SCID (First et al., 1997) was used to
establish current and past DSM IV Axis 1 diagnoses. Estimated full-scale IQ scores were
derived from the Vocabulary and Block Design Tests of the Wechsler Intelligence Scale for
Children—Third Edition (Wechsler, 1991) for individuals younger than 16 years and from
the Wechsler Adult Intelligence Scale—Revised (Wechsler, 1981) for individuals 16 years or
older (Carrion et al., 2013).
Social and role functioning—Social and role functioning were assessed using the GF:
Social Scale and the GF: Role Scale (Cornblatt et al., 2012), two scales specifically designed
to detect change in functioning in at-risk adolescents and young adults who are not as
severely impaired as more chronic patients. The scales were initially validated as part of
collaboration between the Zucker Hillside and UCLA sites, but later used as the common
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social/role measures across NAPLS-1 sites (Cornblatt et al., 2012). The GF: Social Scale
assesses peer relationships, peer conflict, age appropriate intimate relationships, and
involvement with family members. The GF: Role Scale assesses performance and amount of
support needed in one’s specific roles (i.e., school/work). Scores of both scales range from 1
to 10 (with higher scores indicating better functioning). In the present study, we made use of
the “current” functioning scores, that is, functioning levels in the month preceding
assessment. Ratings for each scale were based on best estimates derived from all available
information, an approach that has been shown to yield high interrater reliability scores
(Cannon et al., 2008; Cornblatt et al., 2007).
Follow-up procedure

Author Manuscript

All 6-month interval follow-up interviews included SIPS ratings and the two global
functioning scales. Conversion to psychosis was defined as the presence of a psychotic-level
positive symptom (a score of 6 with a minimum duration of 1 week). For the majority of the
cases, a follow-up SCID interview was conducted at the time of conversion to additionally
determine DSM-IV diagnosis of psychotic disorder.
Statistical analyses

Author Manuscript

Because we were specifically interested in the period between early adolescence and early
adulthood, and the number of data points per age group (specifically for converters) was
substantially lower after this period, we restricted our analyses to participants aged 12–23
years. We included only those participants who had data on social and role functioning, and
IQ scores available. We limited our analyses to data collected on functioning prior to first
onset of psychosis only; thus, data from CHR-C youth gathered after first psychosis onset
was excluded. Interdependence between the two functional domains (i.e., shared variance
between deficits in role and social functioning) was examined with partial correlations,
controlling for age, gender, and IQ. We used regression analyses to examine the association
between functional impairment, age at baseline, and time-to-conversion. Differences in
baseline demographic characteristics, baseline symptoms (positive, negative, disorganized,
or general), IQ, and social and role functioning between the control group, CHR-NC, and
CHR-C individuals were examined with regression analyses for continuous variables, and
chi-square tests for dichotomous variables.

Author Manuscript

Functioning data from the 358 CHR and 164 healthy individuals included in our study (159
with 1 assessment, 363 with >1 assessment, range = 1–5) yielded 1,275 observations
(including first assessment) to construct developmental trajectories. There were a
significantly higher number of dropouts after first assessment among healthy individuals
(43.3%; n = 71) versus in the CHR cohort (24.6%; n = 88). Some follow-up assessments
were not included in the analyses as the participant aged-out of our age window: 9
participants had turned 24 by the time of the second assessment, another 4 by the time of the
third, 2 by the time of the fourth, and 3 more by the time of the fifth assessment. CHR
individuals with only one assessment were comparable to those with >1 on all clinical and
functional measures and most demographic characteristics, but were marginally older (17.6
vs. 17.0; t = 1.98, p = .049). Healthy individuals with only one assessment did not differ
from those with >1 on functional measures and demographic characteristics, but had
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significantly less positive ( p < .001), general ( p = .023), and disorganization symptoms ( p
= .013).
Developmental trajectories of social and role functioning were analyzed separately with
multilevel linear modeling analyses (Statacorp 14; StataCorp, 2014), taking multiple
observations per individual into account. We explored the different functioning
developmental trajectories per status group by entering age of assessment as an independent
variable, and functioning score as the dependent variable in the model (controlling for IQ
and gender). Both the main effect of group (CHR-NC, CHR-C, and controls) and the
Group×Age interaction were effects of interest: a group main effect only would be
suggestive of a static group difference, whereas a Group×Age interaction would be
suggestive of stagnation, faster growth, or decline in functioning in one group compared to
other groups.

Author Manuscript

We subsequently explored whether there were specific periods in the functional development
of future converters that distinguished them from nonconverters by subdividing all social and
role functioning assessments into age bands that capture different developmental epochs:
early adolescence (ages 12–15 years), middle to late adolescence (15–18 years), young
adulthood (18–21 years), and adulthood (21–23 years). We performed multilevel linear
modeling analyses for each age band to identify time periods when levels of functioning in
the CHR-C group started to diverge from the CHR-NC. We controlled for gender and IQ in
these analyses as well.
To explore whether the baseline severity of symptoms attenuated our findings, all analyses
were repeated controlling for positive, negative, general, and disorganization symptoms.

Author Manuscript

Results
Of the 358 CHR participants, 83 converted (23.2%) to a psychotic disorder within the
follow-up period. Diagnostic outcome was available for 70 converters (84.3%). Of those, 36
(51.4%) received a diagnosis in the schizophrenia spectrum (schizophrenia, n = 18;
schizophreniform, n = 11; schizoaffective, n = 7), 9 (12.9%) were diagnosed with a mood
disorder with psychotic features, 19 (27.1%) with a psychosis not otherwise specified, 4
(5.7%) with a brief psychotic episode, and 2 (2.9%) with a delusional disorder.

Author Manuscript

Among those who converted, the mean time from baseline assessment to conversion to
psychosis was 0.88 years (~10 months; SD = 0.81). Average time of follow-up assessment
for the remainder of the sample was 1.19 years (SD = 0.97). Time to conversion was not
significantly associated with social and role functioning at any time point ( p values ranged
between p = .20 and p = .96 for social functioning, and between p = .08 and p = .79 for role
functioning) or with age at baseline (B = –0.05, SE = 0.04, p = .18). Table 1 presents
baseline demographic and clinical data for the 358 CHR participants and the 164 healthy
comparison subjects. CHR individuals overall had lower IQ, and were significantly more
often White and male relative to the comparison group. CHR-NC individuals had fewer
years of education and were younger than CHR-C and the control group.

Dev Psychopathol. Author manuscript; available in PMC 2019 February 01.
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The square of correlations between role and social functioning was .34, indicating a
moderate amount of common variance. We examined the natural course of social
functioning by examining the social functioning data over time in controls. Social
functioning in this group was dynamic, gradually improving with age (B = 0.08, SE = 0.02,
p ≤ .001). Both the CHR-C and CHR-NC groups had lower levels of social functioning over
time relative to the control group (main effect: B = –2.84, SE = 0.17, p < .001; B = –2.04;
SE = 0.12, p < .001). There was a trend toward a Group×Age interaction when comparing
functional trajectories across all groups (B = –0.10, SE = 0.06, p = .073), suggesting that
functional trajectories may differ between groups. Examining this further, we observed that
in contrast to CHR-NC individuals who (in congruence with the healthy control sample)
significantly improved in their social functioning skills with age (B = 0.10, SE = 0.02; p < .
001), the CHR-C group did not show such an increase (B = –0.0002, SE = 0.06, p = .997;
see Figure 1). These findings held when the baseline severity of positive, negative, and
disorganized symptoms were accounted for.
Analyses within the CHR group suggest that there may be two potential periods during
which converters started to lag behind in social functioning compared to nonconverters (see
Table 2). Between ages 15 and 18, the growth seen in premorbid social functioning of
nonconverters was not seen in the converting group (B = –0.84, SE = 0.25, p = .001; Cohen
d = 0.56). Subsequently, a similar period occurred between ages 21 and 23, reflected by a
relatively increasing deficit between converters and from nonconverters (B = –1.53, SE =
0.38; p < .001; Cohen d = 1.07). Controlling for prodromal symptoms did not attenuate the
results.

Author Manuscript

GF: Role functioning trajectories
Similarly, in the domain of role functioning, controls marginally improved with age (B =
0.04, SE = 0.02, p = .04). Although an overall group difference was apparent (with the CHRC and CHR-NC groups having lower role functioning scores compared to the control group;
main effect: B = –2.75, SE = 0.20, p < .001; B = –2.05; SE = 0.14, p < .001), here there was
no indication of a Group × Age interaction. Adjusting the analyses for prodromal symptom
severity at baseline did not alter the results.

Author Manuscript

However, examining the developmental trajectories per group separately, we found the
CHR-C group to show greater impairment in role functioning compared to CHR-NC
between ages 12 and 15 (B = –1.60; SE = 0.55; p = .004; Co-hen d = 0.81). In addition, we
detected a similar difference for role functioning between CHR-C and CHR-NC as observed
for the social trajectories (see Figure 1) between the ages of 21 and 23 (B = –0.94, SE =
0.37, p = .01; Cohen d = 0.83). This latter effect decreased to trend level when negative
symptoms or disorganization symptoms were accounted for (B = 0.74; SE = 0.45, p = .08,
and B = –0.78, SE = 0.45, p = .059, respectively).
Converters and nonconverters between ages 21 and 23 were otherwise largely comparable to
those with data at earlier ages. Apart from a higher IQ score in nonconverters age 21–23
compared to the nonconverters in the younger group (IQ = 106.0 vs. IQ = 113.4; p = .02),
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the CHR-C and CHR-NC groups with data between ages 21 and 23 did not significantly
differ from the those with data at earlier ages in terms of positive, negative, general, or
disorganization symptoms, nor in terms of ethnicity or gender.

Discussion
In a large sample of youth at high clinical risk for psychosis, we evaluated whether there are
periods of change in the development of two key components of community functioning:
social and role functioning. Taken together, our results indicate that both social and role
functioning are more impaired in CHR individuals compared to controls from as early as age
12, and that differences between converters and nonconverters become increasingly apparent
by age.

Author Manuscript

In congruence with the literature (Shapiro et al., 2009), functional levels of controls
gradually increased with age. For social functioning, there were periods of early and late
dynamic changes that distinguished CHR-C from CHR-NC, and results remained consistent
when time to conversion was accounted for. During the first period, between ages 15 and 18,
social functioning of converters stagnated and diverged from that of nonconverters, who, like
controls, continued to improve. Next, the growth seen in nonconverters between ages 21 and
23 was not apparent for converters, further distinguishing them from nonconverters. Similar
changes were observed for role functioning, with functioning levels that were lower in the
CHR cohort, but initially increasing in a similar pace for both converters and nonconverters
relative to the functional improvement observed in controls. However, a late change in role
functioning became apparent for the converter group, as their role functioning scores seemed
to stagnate between ages 21 and 23.

Author Manuscript
Author Manuscript

Similar patterns have been observed in a cross-sectional cohort (Velthorst et al., 2015) and in
various retrospective studies to patients diagnosed with schizophrenia using the Premorbid
Adjustment Scale (Allen et al., 2005; Monte et al., 2008; Shapiro et al., 2009; Strauss et al.,
2012). The initial more pronounced difference in trajectories for social functioning between
converters and nonconverters may be at least partly explained by findings of previous work
from our research group, showing that social and role functional outcome may be driven by
different cognitive functions (Carrion et al., 2013; Meyer et al., 2014). In this study,
processing speed performance appeared to be particularly important for social outcome,
while verbal memory was found more strongly related to successful academic and work
achievement. Population-based studies point to an accelerated deficit in processing speed
from the age of 13 in children who will develop adult schizophrenia, which could explain
the stagnation in social functioning around that time (Meier et al., 2014; Reichenberg et al.,
2010). In contrast, impairment in verbal memory has been found to be more stable (Stone et
al., 2016), possibly accounting for the initially more subtle deficits in role functioning.
As argued previously, although accounting for baseline prodromal symptom severity did not
alter our results, the subsequent period of stagnation in both social and role functioning in
early adulthood may be caused by the interaction between prodromal symptoms and the
increasingly complexity of social and work tasks that have to be taken on (Hafner et al.,
1999; Velthorst et al., 2009). While in early adolescence support systems may still

Dev Psychopathol. Author manuscript; available in PMC 2019 February 01.

VELTHORST et al.

Page 9

Author Manuscript

compensate and hide subtle functional deficits, early adulthood represents a phase during
which people are no longer expected to heavily rely on others, potentially contributing to the
increasing deficits during this time. It will be interesting for future studies to disentangle
how stagnation in functional impairment may in turn directly contribute to increased risk of
psychosis onset in the CHR samples; for example, it may be that functional impairment
creates social distress, or reduces access to social support.

Author Manuscript
Author Manuscript

This study has several limitations. First, the minimum age of study participants was 12. We
are therefore constrained to conclusions about functional trajectories, and symptom
development only from this age onward. It would be interesting for future prospective
population-based cohort studies to examine at which age first symptoms and functional
impairments appear. Second, “a significant drop in functioning” was one of the necessary
criteria for individuals included based on schizotypal personality disorder diagnosis.
However, in our study only 0.8% of the CHR individuals were included solely based on the
criterion “first-degree relative with psychosis or patient with schizotypal personality disorder
and a 30% drop in global assessment of functioning score compared with that 1 year ago,
sustained over the past month,” and omitting those subjects from the analyses did not
significantly impact the results. Third, many, but not all, individuals who go on to develop
psychosis experience subthreshold symptoms, and our conclusions are limited to those who
do. In addition, some CHR subjects may convert to psychosis after the 2.5-year follow-up
period (Nelson et al., 2013), and some converters may only have experienced brief fullblown psychotic complaints. Fourth, the potential misclassification of some subjects may
have reduced differences observed between converters and nonconverters (Seidman et al.,
2010). Because controls with DSM-IV psychiatric diagnosis were excluded, the control
group may represent a higher functioning subgroup of the general population. However, the
divergence in functioning we observed between CHR-C and CHR-NC would suggest that
our findings are not simply a result of general distress, but are related to subsequent
development of psychosis. Fifth, the sample size of converters in the 12–15 and 21–23 age
bands was relatively small, and findings with regard to these age epochs should be
interpreted with caution. Sixth, the lack of an association between time to conversion and
functioning scores may have been partly accounted for by limited variability in the time to
conversion, with the majority converting within the first year. Seventh, data on ongoing
(pharmacological) interventions was not taken into account.

Author Manuscript

Despite these limitations, our study is largely consistent with results of previous studies,
which suggest that early stagnation in social functioning may be a unique risk marker for
psychosis (e.g., Cannon et al., 2008; Strauss et al., 2012; Velthorst et al., 2010). Our findings
also provide new evidence supporting the neurodevelopmental model of psychosis, pointing
to a developmental lag in social functioning between the ages of 15 and 18, followed
byanother period of stagnation in earlyadulthood. Results we found related to age rather than
to greater levels of functional impairment in those closer to overt illness. Role functioning
trajectories of converters and nonconverters were initially more comparable, although also
for role functioning, a period of relatively increasing impairment in early adulthood became
apparent for the converting group.
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Moreover, our findings further highlight the importance of examining social and role
functioning separately, and moving away from “global” measures to more age-specific
measures (Cornblatt et al., 2007). Treatment attempts to improve social functioning in
psychotic disorders have been only marginally successful (Almerie et al., 2015), which may
be partly due to the global measures used, as well as our limited knowledge of when
deviations develop. Our results indicate that impaired social and role functioning in CHR
individuals are apparent already in early adolescence, but that functioning levels of
converters further diverge from nonconverters in early adulthood. We found middle
adolescence to be a first period of change in the development of social functioning, as during
this time trajectories of those with and without a psychotic disorder start to diverge.
Worldwide, noninvasive cognitive (behavioral) interventions for young individuals at risk for
psychosis are emerging (Addington, Epstein, et al., 2011; Landa et al., 2016; Okuzawa et al.,
2014; van der Gaag et al., 2012, 2013) with few also focusing on the improvement of social
functioning, or the preservation of social engagement (for a review, see Thompson et al.,
2015). Certain cognitive interventions (e.g., see French & Morrison, 2004) may be
promising in impeding the deteriorating functional course of adolescents at risk for
psychosis.

Author Manuscript

It will be important for future studies to disentangle what neural and genetic processes
contribute to this diversion and how these processes vary across different functions. The
significance of these future studies has been highlighted by Hodgekins et al. (2015) who
found that a large proportion of individuals with significant social disability do not improve
over the first 12 months of service provision (66%).
Conclusion

Author Manuscript

In conclusion, our findings provide new insight into the developmental course of functioning
in youth at CHR for psychosis, and inform the field about potentially important intervention
windows. We hope that a better understanding of the origins and developmental course of
functional impairment will ultimately help us decrease its debilitating consequences and
increase our knowledge of the pathways to psychotic disorders.
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Figure 1.

(Color online) Developmental trajectories of social and role functioning. The Y-axis in the
figure represents the GF: Social Scale and the GF: Role Scale scores, which range from 1 to
10, with higher scores meaning better functioning. The X-axis represents mean scores at the
assessments conducted with individuals at ages 12–15, 15–18, 18–21, and 21–23.
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Baseline demographic and clinical characteristics of the sample
CHR
Statistics*

Converters (n = 83)

Nonconverters (n = 275)

Controls (n = 164)

59 (69.9)

175 (63.3)

77 (47.0)

1, 2 > 3

17.98 (2.51)

16.86 (2.90)

17.91 (3.25)

1, 3 > 2

55 (68.75)

192 (73.28)

96 (61.54)

1, 2 > 3

102.72 (19.65)

106.72 (15.99)

111.51 (13.46)

1, 2 < 3

10.86 (2.02)

9.85 (2.68)

10.95 (2.94)

1, 3 > 2

17 (35.42)

54 (29.83)

19 (14.62)

1, 2 > 3

Social, mean (SD)

5.49 (1.43)

6.21 (1.50)

8.61 (0.99)

1<2<3

Role, mean (SD)

5.45 (1.74)

6.12 (1.88)

8.62 (0.97)

1<2<3

Positive symptoms

14.00 (4.58)

10.77 (3.92)

0.89 (1.58)

1>2>3

Negative symptoms

15.31 (6.87)

11.70 (6.54)

0.97 (1.62)

1>2>3

Disorganized symptoms

8.25 (4.57)

5.51 (3.50)

0.39 (0.77)

1>2>3

General symptoms

9.38 (4.46)

7.57 (4.05)

0.61 (1.05)

1>2>3

Variable
Gender, no male (%)
Age at baseline, mean (SD)
White,a n (%)
IQ at baseline, mean (SD)
Years of education, mean (SD)
Lower educational level father,b n (%)
GF

Author Manuscript

SIPS

Note: CHR, Clinical high risk; GF, global functioning; SIPS, Structured Interview for Prodromal Syndromes. Scores represent SIPS and GF at
baseline.
a

Data for n = 24 missing.

b

Number of individuals without education higher than high school. Data for n = 163 missing.

*

p = .05.
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−1.53

21–23

−0.43

−0.64

−0.98

15–18

18–21

21–23

0.37

0.32

0.32

0.55

0.38

0.28

0.25

0.47

SE

−2.68

−1.98

−1.36

−2.91

−4.01

−2.41

−3.33

−1.18

Z

.007

.048

.173

.004

<.0001

.02

.001

.240

p

[−0.07, −0.26]

[−1.26, −0.007]

[−1.05, 0.189]

[−2.69, −0.52]

[−2.27, −0.78]

[−1.23, −0.13]

[−1.32, −0.34]

[−1.47, 0.37]

CI 95%

Note: CHR, Clinical high risk; GF, global functioning. All analyses are controlled for IQ and gender. Number of data points: 12–15 years: CHR converters (CHR-C), n = 25; CHR nonconverters (CHR-NC),
n = 228; 15–18 years: CHR-C, n = 76; CHR-NC, n = 377; 18–21 years: CHR-C, n = 86; CHR-NC, n = 251; 21–23 years: CHR-C, n = 27; CHR-NC, n = 125.

−1.60

12–15

Role

−0.68

−0.83

15–18

18–21

−0.55

B

12–15

Social

GF

Difference in social and role functioning between CHR converters and nonconverters per age band
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